Alyse Young works collaboratively with her clients to achieve their goals through a variety of transactions and finance matters. She concentrates her practice on representing both lenders and borrowers in debt financing transactions. Alyse’s borrower clients operate across a number of sectors and include both middle-market and emerging companies. She also represents private equity firms and other institutional investors in financing the acquisition and ongoing funding of their portfolio companies.
On the lender side, Alyse represents clients in various financing transactions, including acquisition financing and commercial real estate financing. In addition, she has experience advising nonprofits, development finance institutions and governmental agencies in international financings, project finance and social impact investments.
Alyse also has significant experience advising on the full range of corporate matters, including acquisitions, divestitures, mergers, corporate reorganizations and general corporate governance matters.
Alyse serves on the firm’s Pro Bono Committee and enjoys working on pro bono matters, such as humanitarian immigration relief for victims of human trafficking.
Speaker, Best Practices in Preparing Corporate Minutes, The Association of Corporate Counsel, Webinar, September 25 2018
Member, NC Pro Bono Resource Center Advisory Board
Any result the lawyer or law firm may have achieved on behalf of clients in other matters does not necessarily indicate similar results can be obtained for other clients.
- Represented financial institutions and government agencies in international project finance and microfinance transactions in South America, Middle East, Central America, Africa and Asia.
- Advises nonprofit corporations, including continuing care retirement communities (CCRCs), in a variety of corporate governance and regulatory compliance matters.
- Advises early stage ventures on formation, corporate governance and equity financing.
- Represented a private company in negotiating and navigating the sale of its majority interest, valued at $1.5 billion.